These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22672280)

  • 41. [Melasma and aspects of pigmentary disorders in Asians].
    Kang HY
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S92-5. PubMed ID: 23260524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Melasma: a comprehensive update: part II.
    Sheth VM; Pandya AG
    J Am Acad Dermatol; 2011 Oct; 65(4):699-714. PubMed ID: 21920242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenol-castor oil: modified peel for dermal melasma.
    Piamphongsant T
    Dermatol Surg; 2006 May; 32(5):611-7; discussion 617. PubMed ID: 16706754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melasma.
    Doolan BJ; Gupta M
    Aust J Gen Pract; 2021 Dec; 50(12):880-885. PubMed ID: 34845463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Origin, clinical presentation, and diagnosis of facial hypermelanoses.
    Nicolaidou E; Antoniou C; Katsambas AD
    Dermatol Clin; 2007 Jul; 25(3):321-6, viii. PubMed ID: 17662897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Finasteride associated melasma in a Caucasian male.
    Famenini S; Gharavi NM; Beynet DP
    J Drugs Dermatol; 2014 Apr; 13(4):484-6. PubMed ID: 24719069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Melasma : An update on the clinical picture, treatment, and prevention].
    Becker S; Schiekofer C; Vogt T; Reichrath J
    Hautarzt; 2017 Feb; 68(2):120-126. PubMed ID: 28084498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perspectives of topical formulations for melasma.
    de Freitas ACP; Rigon RB; Bagatin E; Leonardi GR
    Int J Dermatol; 2023 Feb; 62(2):260-268. PubMed ID: 36083295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Melasma and aspects of pigmentary disorders in Asians.
    Kang HY
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S144-7. PubMed ID: 23522629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Melasma: Updates and perspectives.
    Kwon SH; Na JI; Choi JY; Park KC
    Exp Dermatol; 2019 Jun; 28(6):704-708. PubMed ID: 30422338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beneficial effects of spraying low mineral content thermal spring water after fractional photothermolysis in patients with dermal melasma.
    Barolet D; Lussier I; Mery S; Merial-Kieny C
    J Cosmet Dermatol; 2009 Jun; 8(2):114-8. PubMed ID: 19527335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What's new in objective assessment and treatment of facial hyperpigmentation?
    Molinar VE; Taylor SC; Pandya AG
    Dermatol Clin; 2014 Apr; 32(2):123-35. PubMed ID: 24679999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of melasma in Brazilian patients: a multicenter study.
    Hexsel D; Lacerda DA; Cavalcante AS; Machado Filho CA; Kalil CL; Ayres EL; Azulay-Abulafia L; Weber MB; Serra MS; Lopes NF; Cestari TF
    Int J Dermatol; 2014 Apr; 53(4):440-4. PubMed ID: 23967822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is non-ablative 1550-nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients.
    Karsai S; Fischer T; Pohl L; Schmitt L; Buhck H; Jünger M; Raulin C
    J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):470-6. PubMed ID: 21569111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physical signs for the general dental practitioner. Case 45. Melasma.
    Bain S
    Dent Update; 2007 Jun; 34(5):316. PubMed ID: 17624149
    [No Abstract]   [Full Text] [Related]  

  • 56. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women.
    Lakhdar H; Zouhair K; Khadir K; Essari A; Richard A; Seité S; Rougier A
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):738-42. PubMed ID: 17567299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Facial melanoses: Indian perspective.
    Khanna N; Rasool S
    Indian J Dermatol Venereol Leprol; 2011; 77(5):552-63; quiz 564. PubMed ID: 21860153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A review of combined treatments for melasma involving energy-based devices and proposed pathogenesis-oriented combinations.
    Mehrabi JN; Bar-Ilan E; Wasim S; Koren A; Zusmanovitch L; Salameh F; Isman Nelkenbaum G; Horovitz T; Zur E; Song Lim T; Mashiah J; Artzi O
    J Cosmet Dermatol; 2022 Feb; 21(2):461-472. PubMed ID: 33794033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [How I treat... facial melasma].
    Piérard GE
    Rev Med Liege; 1997 Feb; 52(2):58-9. PubMed ID: 9173482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.